VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait

L Poirel; V O Rotimi; E M Mokaddas; A Karim; P Nordmann

doi:10.3201/eid0703.010322

VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait

Emerg Infect Dis. 2001 May-Jun;7(3):468-70. doi: 10.3201/eid0703.010322.

Authors

L Poirel¹, V O Rotimi, E M Mokaddas, A Karim, P Nordmann

Affiliation

¹ Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France.

Abstract

Two clinical Pseudomonas aeruginosa isolates from patients in intensive care units in Kuwait were resistant to expanded-spectrum cephalosporins and showed a synergistic effect between ceftazidime and clavulanic acid. This is the first report of extended-spectrum enzymes from nosocomial isolates from the Middle East.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Amino Acid Sequence
Escherichia coli Proteins
Humans
Kuwait
Molecular Sequence Data
Polymerase Chain Reaction
Pseudomonas aeruginosa / enzymology*
beta-Lactamases / chemistry
beta-Lactamases / genetics
beta-Lactamases / metabolism*

Substances

Escherichia coli Proteins
beta-lactamase VEB-1, E coli
beta-Lactamases